DEED OF CONTINUING GUARANTEE BY TEVA PHARMACEUTICAL INDUSTRIES LIMITED IN FAVOUR OF BANK HAPOALIM B.M. PURSUANT TO THE LOAN AGREEMENT DESCRIBED BELOW, ENTERED IN THIS DAY BETWEEN BANK HAPOALIM B.M. AND TEVA PHARMACEUTICALS USA, INC.Deed of Continuing Guarantee • December 8th, 2008 • Teva Pharmaceutical Industries LTD • Pharmaceutical preparations
WHEREAS TEVA PHARMACEUTICALS USA, INC. (Company Registration No. 22-1734359), a company registered under the laws of the state of Delaware, United States of America (“the Company”) a wholly owned subsidiary of Teva Pharmaceutical Industries Limited (“the Guarantor”) has received from Bank Hapoalim B.M. (“the Bank”), a loan in the total principal amount of US$ $1,000,000,000 (one billion US Dollars) according to a loan agreement dated this day signed between the Company, the Bank and the Lenders (as such term is defined therein), attached hereto as Schedule A, as shall be amended and/or replaced from time to time (hereinafter: the “Loan Agreement”) and subject to its terms and conditions (hereinafter: the “Loan”);
